Maverix Biomics Closes $6 Million Series A Round for Proven Gene Expression Data Analysis Company
January 7, 2014
SAN MATEO, Calif. -- Maverix Biomics, Inc., a leading provider of software for next-generation sequencing genomic data analysis, today announced that it has closed a $6 million Series A funding round. The company's pioneering flagship offering, the Maverix Analytic Platform, simplifies complex big data analytics for life science researchers; integrating context-based data exploration, interactive visualization, [...]
ENZO BIOCHEM ANNOUNCES UPCOMING LITIGATION SCHEDULE
January 7, 2014
NEW YORK - Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo”, “the Company”) today issued an update on its ongoing litigation surrounding the protection of its intellectual property and contractual rights. Two of the cases, in which Enzo is the Plaintiff, are scheduled for jury trials. Both cases will be tried in the United States District Court [...]
January 7, 2014
COLUMBIA, Md. – Shimadzu Scientific Instruments Inc. has introduced the SALD-7500nano, a highly sensitive particle size analyzer that can accurately measure nanoparticles in low concentrations or those that demonstrate high light absorption. The analyzer also provides real-time tracing of changes across a wide range of particle sizes. The SALD-7500nano analyzer offers significantly improved sensitivity for [...]
Ready-to-Use Stable Cell Lines
January 6, 2014
AMSBIO has expanded its portfolio of stable cell lines. The new cell lines express endogenous or recombinant proteins and are available in a ready-to-use format to facilitate your research efforts. Using AMSBIO stable cell lines not only provides an optimized solution for manufacture of therapeutic and diagnostic protein, but also for applications in drug screening, [...]
Watson-Marlow Pumps Group acquires Bio Pure Technology Limited
January 6, 2014
Watson-Marlow Pumps Group (WMPG) strengthens its single-use biopharmaceutical offering through acquisition of Bio Pure Technology Limited (Bio Pure). Watson-Marlow, a world-leading positive displacement pump manufacturer, has acquired Bio Pure through its parent company Spirax-Sarco Engineering plc for £8.5 million. Bio Pure, based in Portsmouth UK, specialises in the design and production of advanced single-use tubing [...]
Invisible Sentinel and Jackson Family Wines Partner on Diagnostic for the Wine Industry
January 6, 2014
Philadelphia, Pennsylvania – Invisible Sentinel Inc., a life- sciences company that develops and manufactures rapid molecular diagnostics for the food industry, announced today that it will partner with Jackson Family Wines, the family-owned winery in Sonoma County, on a first-in-class rapid diagnostic to detect Brettanomyces, a wine-spoiling yeast. The diagnostic assay, called Veriflow® BRETT, will [...]
FEDERAL COURT AWARDS ENZO BIOCHEM OVER $61 MILLION IN PATENT INFRINGEMENT DAMAGES
January 6, 2014
NEW YORK – Enzo Biochem Inc. (NYSE:ENZ) reported today that a Federal Court Judge in New Haven, CT, in connection with the favorable November 2012 jury finding of direct infringement damages of Enzo patents by Applera Corp., now Life Technologies Inc. (NASDAQ:LIFE), has awarded the Company prejudgment interest of $12,428,729, bringing the total award to [...]
Gas Chromatography Options Designed to Conserve Helium, Boost Flexibility, Add Usability
January 6, 2014
SAN JOSE, Calif. -– Scientists using gas chromatography (GC)can enjoy a number of new options with the Thermo Scientific TRACE 1300 Series GC system, designed to conserve helium, permit use of multiple detectors simultaneously, automate sampling gas workflows, and perform flame photometric detection. New options for the TRACE 1300 Series GC platform include: • Instant [...]
January 6, 2014
WALTHAM, Mass. -- Thermo Fisher Scientific (NYSE:TMO), the world leader in serving science, today announced that it has signed an agreement to sell its cell culture (sera and media), gene modulation and magnetic beads businesses to GE Healthcare, a unit of General Electric Company (NYSE: GE), for approximately $1.06 billion. The businesses will become part [...]
GE to expand in life sciences with acquisition of strategic assets from Thermo Fisher Scientific
January 6, 2014
CHALFONT ST. GILES, UK – GE (NYSE:GE) and Thermo Fisher Scientific (NYSE:TMO) announced today that they have entered into an agreement for GE Healthcare to acquire Thermo Fisher’s HyClone™ cell culture media and sera, and gene modulation and magnetic beads businesses for approximately $1.06 billion. The acquisition will allow GE to expand its offering of [...]
